What exactly is a mood stabilizer?
作者信息
Young L Trevor
出版信息
J Psychiatry Neurosci. 2004 Mar;29(2):87-8.
Abstract
摘要
相似文献
1
What exactly is a mood stabilizer?
J Psychiatry Neurosci. 2004 Mar;29(2):87-8.
2
Increasing sophistication of the pharmacotherapy of mood disorders.
J Psychiatry Neurosci. 2002 Mar;27(2):89.
3
[Mechanism and clinical effects of drugs for mood disorder].
Ryoikibetsu Shokogun Shirizu. 2003(38):358-61.
4
Mood stabilizers for patients with bipolar disorder: the state of the art.
Expert Rev Neurother. 2011 Jan;11(1):85-99. doi: 10.1586/ern.10.181.
5
Algorithms for the treatment of affective illness, primary disorder of vigilance, and task-dependent attention disorders (learning disabilities) in children and adolescents.
J Child Neurol. 1996 May;11(3):220-7. doi: 10.1177/088307389601100312.
6
Adolescent psychopharmacology: drugs for mood disorders.
Adolesc Med Clin. 2006 Oct;17(3):789-808; abstract xiii-xiv. doi: 10.1016/j.admecli.2006.06.003.
7
Lithium in neuropsychiatry: a 2010 update.
World J Biol Psychiatry. 2011 Aug;12(5):340-8. doi: 10.3109/15622975.2011.559274. Epub 2011 Mar 2.
8
Mood disorders and dental implications.
J Mass Dent Soc. 2003 Fall;52(3):38-42.
9
[Mood disorders. Bipolar psychosis].
Rev Prat. 2004 Apr 30;54(8):877-83; quiz 884.
10
Atypical mood stabilizers: a new role for neuroleptics?
Bipolar Disord. 2011 Nov-Dec;13(7-8):583-6. doi: 10.1111/j.1399-5618.2011.00967.x.
引用本文的文献
1
Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression.
Ther Adv Psychopharmacol. 2021 May 19;11:20451253211011021. doi: 10.1177/20451253211011021. eCollection 2021.
2
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression.
Neuropsychiatr Dis Treat. 2020 Oct 29;16:2539-2551. doi: 10.2147/NDT.S273287. eCollection 2020.
3
Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder.
Neuropsychiatr Dis Treat. 2020 May 12;16:1199-1206. doi: 10.2147/NDT.S245911. eCollection 2020.
4
Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.
Neuropsychopharmacol Rep. 2020 Sep;40(3):224-231. doi: 10.1002/npr2.12109. Epub 2020 May 26.
5
The diagnostic dilemma: why we need to change how we diagnose bipolar disorder in children.
Cerebrum. 2010 Nov;2010:23. Epub 2010 Nov 10.
6
Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.
Psychopharmacology (Berl). 2011 Aug;216(4):485-99. doi: 10.1007/s00213-011-2243-2. Epub 2011 Mar 10.
7
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):1-16. doi: 10.1007/s00406-005-0591-9. Epub 2005 Aug 4.
本文引用的文献
1
Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.
Am J Psychiatry. 2004 Feb;161(2):217-22. doi: 10.1176/appi.ajp.161.2.217.
2
What is a "mood stabilizer"? An evidence-based response.
Am J Psychiatry. 2004 Jan;161(1):3-18. doi: 10.1176/appi.ajp.161.1.3.
3
Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) expression and localization.
J Neurosci Res. 2003 Dec 15;74(6):942-7. doi: 10.1002/jnr.10832.
4
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. doi: 10.1001/archpsyc.60.11.1079.
5
The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry.
Can J Psychiatry. 2003 Aug;48(7):433-9. doi: 10.1177/070674370304800702.
6
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
Am J Psychiatry. 2003 Jul;160(7):1263-71. doi: 10.1176/appi.ajp.160.7.1263.
7
Finding the intracellular signaling pathways affected by mood disorder treatments.
Neuron. 2003 Apr 24;38(2):157-60. doi: 10.1016/s0896-6273(03)00195-8.
8
Practice guideline for the treatment of patients with bipolar disorder (revision).
Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50.
9
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
Am J Psychiatry. 1999 Aug;156(8):1164-9. doi: 10.1176/ajp.156.8.1164.
Zotero 插件